Page last updated: 2024-12-10
sw044248
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
SW044248: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 3152990 |
| MeSH ID | M0590112 |
Synonyms (28)
| Synonym |
|---|
| OPREA1_566576 |
| EU-0048121 |
| STK119518 |
| 2-[(5-ethyl-5h-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-n-(2-methoxyphenyl)butanamide |
| AKOS000716421 |
| HMS1615G08 |
| 2-[(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-n-(2-methoxyphenyl)butanamide |
| S6747 |
| AKOS022084052 |
| sw044248 |
| 522650-83-5 |
| CS-5386 |
| HY-19637 |
| AC-35327 |
| 2-(5-ethyl-5h-[1,2,4]triazino[5,6-b]indol-3-ylthio)-n-(2-methoxyphenyl)butanamide |
| sw044248, >=98% (hplc) |
| mfcd03487851 |
| sw-044248 |
| 2-((5-ethyl-5h-[1,2,4]triazino[5,6-b]indol-3-yl)thio)-n-(2-methoxyphenyl)butanamide |
| BCP16844 |
| sw 044248 |
| EX-A2360 |
| 2-(5-ethyl-5h-[1,2,4]triazino[5,6-b]indol-3-ylthio)-n-(2-methoxyphenyl)butanamide;sw044248 |
| A857426 |
| nsc-789797 |
| nsc789797 |
| AS-77801 |
| 2-[(5-ethyl-5h-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-n~1~-(2-methoxyphenyl)butanamide |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (4)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 13.13
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.13) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||